![](https://www.optumhealtheducation.com/sites/default/files/styles/course_image/public/course/2022-08/2022%20Website%20Upgrade%20-%20Default%20Course%20Image.jpg?itok=WPUfrdXW)
CRISPR Technology and the Potential Applications for Treating Diseases
Activity description
This activity consists of recorded presentations from "Essentials of Oncology, Solid Organ and Blood/Marrow Transplant Management for the Health Care Team" held virtually May 5–6, 2021.
CRISPR—an acronym for clusters regularly interspaced short palindromic repeats—is a simple yet powerful tool for editing genomes. It has rapidly established itself as an important therapeutic tool that allows DNA sequences to be altered and gene function to be modified by researchers. CRISPR has the potential for treating a range of medical conditions that have a genetic component. This session will provide an overview of CRISPR, its challenges, ethical concerns, and the role it plays in developing therapies.
Provided by
This activity is provided by OptumHealth Education.
Commercial support
There was no commercial support for this activity.
Required hardware/software
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.
Target Audience
This activity is designed to meet the educational needs of case managers, nurses, pharmacists, pharmacy technicians, physicians, psychologists, social workers and other health care professionals who are interested in an overview of CRISPR.
Learning Objectives
At the end of this educational activity, participants should be able to:
- Provide an overview of CRISPR.
- Describe CRISPR’s potential role in treating medical conditions.
- Discuss current challenges of CRISPR for future therapeutic applications.
- State the ethical concerns with CRISPR.
Additional Information
Attachment | Size |
---|---|
![]() | 4.03 MB |
Faculty
![]() | John F. DiPersio, MD, PhD Virginia E and Samuel J Golman Professor of Medicine Chief, Division of Oncology Director, Center for Gene and Cellular Immunotherapy Deputy Director, Siteman Cancer Center Washington University School of Medicine St. Louis, MO |
Planning Committee
Elizabeth Albert, MD
Clinical Activity Manager
OptumHealth Education
Eden Prairie, MN
Rebecca Gleason, RN, CCM
Clinical Activity Manager
OptumHealth Education
Eden Prairie, MN
Alan N. Langnas, DO, FACS
Professor of Surgery
Director, Center of Transplantation
Chief, Section of Transplantation,
Department of Surgery
University of Nebraska Medical Center;
Director of Liver Transplantation
Nebraska Medicine
Omaha, NE
C. Fred LeMaistre, MD
Senior Vice President, Market Operations
Physician-in-Chief, Hematology
Sarah Cannon
Nashville, TN
Tina Rydland, PharmD
Crystal Clear Rx
Denver, CO
Crystal Wong, MD
President
Propoint Medical Writing
Wexford, PA
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, OptumHealth Education (OHE) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. OHE ensures that the content is independent of commercial bias.
Dr. DiPersio serves as a consultant and/or on an Advisory Board for Incyte, Rivervest, Bioline, CelIncyte, NeoImuneTech, Macrogenics, Cellworks Group Inc., Magenta, WUGEN; he holds stock/ownership interest in Magenta, WUGEN; and he receives grant/research support from Amphivena Therapeutics, NeoImmune Tech, Macrogenics, Incyte, Bioline Rx, and WUGEN.
The activity planners have no financial relationships to disclose.
Method for calculating CE credit
CE credit was calculated by the complexity of content.
Accreditation StatementIn support of improving patient care, OptumHealth Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit Designation Statements
Nurses
The participant will be awarded up to 1.0 contact hour(s) of credit for attendance and completion of supplemental materials.
Nurse practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
Pharmacists/Pharmacy technicians
This activity is approved for 1.0 contact hour(s) ([0.10] CEU) in states that recognize ACPE.
Attending the full program will earn 1.0 contact hour(s).
Unique Activity Number(s): JA0007123-0000-21-170-H04-P/T
Physicians
OptumHealth Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PAs
The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.
Case managers
The Commission for Case Manager Certification has approved this program for a maximum of 1.0 clock hour(s) for Certified Case Managers (CCM).
Psychologists and social workers
Participants must have attended the entire Web-based activity and completed an evaluation to receive a certificate. Partial credit is not available.
Psychologists
OptumHealth Education is approved by the American Psychological Association (APA) to offer continuing education for psychologists. OptumHealth Education maintains responsibility for this program. 1.0 CE hour.
Social Workers
As a Jointly Accredited Organization, OptumHealth Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. OptumHealth Education maintains responsibility for this course. Social workers completing this course receive 1.0 enduring continuing education credit. |
Attendance
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization with which they wish to obtain credit.
Available Credit
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 CCMC - General - Case Managers
Prior to beginning this activity, please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.
You must be logged into your account to participate in this activity. Get started by clicking “Continue” and taking the “Pre-Activity Assessment”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account”, “My Activities.”